Tissue transglutaminase expression in human breast cancer

Laboratory Investigation

Volumn 75, Issue 5, 1996, Pages 637-645

  Hettasch, Joann M ^a   Bandarenko, Nicholas ^a,b   Burchette, James L ^a   Lai, Thung Shenq ^a   Marks, Jeffrey R ^a,b   Haroon, Zishan A ^a   Peters, Kevin ^a   Dewhirst, Mark W ^a,b   Iglehart, J Dirk ^a,b   Greenberg, Charles S ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; VON WILLEBRAND FACTOR;

ARTICLE; BREAST CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPEROXIDASE STAINING; IN SITU HYBRIDIZATION; INTRADUCTAL CARCINOMA; INVASIVE CARCINOMA; PRIORITY JOURNAL; STROMA CELL;

BREAST NEOPLASMS; EXTRACELLULAR MATRIX; FEMALE; GTP PHOSPHOHYDROLASES; GTP-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; TRANSGLUTAMINASES;

EID: 10544254255     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Aeschlimann D, Kaupp O, and Paulsson M (1995). Transglutaminase-catalyzed matrix cross-linking in differentiating cartilage: Identification of osteonectin as a major glutaminyl substrate. J Cell Biol 129:881-892.
2. Aeschlimann D and Paulsson M (1991). Cross-linking of laminin-nidogen complexes by tissue transglutaminase: A novel mechanism for basement membrane stabilization. J Biol Chem 266:15308-15317.
3. Aeschlimann D and Paulsson M (1994). Transglutaminases: Protein cross-linking enzymes in tissues and body fluids. Thromb Haemost 71:402-415.
4. Aeschlimann D, Paulsson M, and Mann K (1992). Identification of Gln726 in nidogen as the amine acceptor in transglutaminase-catalyzed cross-linking of laminin-nidogen complexes. J Biol Chem 267:11316-11321.
5. Aeschlimann D, Wetterwald A, Fleisch H, and Paulsson M (1993). Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes. J Cell Biol 120:1461-1470.
6. Barcellos-Hoff MH, Aggeler J, Ram TG, and Bissell MJ (1989). Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane. Development 105:223-235.
7. Barnard JA, Lyons RM, and Moses HL (1990). The cell biology of transforming growth factor beta. Biochim Biophys Acta 1032:79-87.
8. Bendixen E, Borth W, and Harpel PC (1993). Transglutaminases catalyze cross-linking of plasminogen to fibronectin and human endothelial cells. J Biol Chem 268:21962-21967.
9. Beninati S, Abbruzzese A, and Cardinali M (1993). Differences in the post-translational modification of proteins by polyamines between weakly and highly metastatic B16 melanoma cells. Int J Cancer 53:792-797.
10. Beninati S, Senger DR, Cordella-Miele E, Mukherjee AB, Chackalaparampil I, Shanmugam V, Singh K, and Mukherjee BB (1994). Osteopontin: Its transglutaminase-catalyzed post-translational modifications and cross-linking to fibronectin. J Biochem (Tokyo) 115:675-682.
11. Bissell MJ and Hall HG (1987). Form and function in the mammary gland: The role of the extracellular matrix. In: Neville MC and Daniel CW, editors. The mammary gland: Development, regulation, and function. New York: Plenum Press, 97-146.
12. Blood CH and Zetter BR (1990). Tumor interactions with the vasculature: Angiogenesis and tumor metastasis. Biochim Biophys Acta 1032:89-118.
13. Bowness JM, Folk JE, and Timpl R (1987). Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen. J Biol Chem 262:1022-1024.
14. Civin CI, Strauss LC, Brovall C, Fackler MJ, Schwartz JF, and Shaper JH (1984). Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 133:157-165.
15. Cooper DN and Barondes SH (1990). Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism. J Cell Biol 110:1681-1691.
16. Edgell CJ, McDonald CC, and Graham JB (1983). Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci USA 80:3734-3737.
17. Fina L, Molgaard HV, Robertson D, Bradley NJ, Monaghan P, Delia D, Sutherland DR, Baker MA, and Greaves MF (1990). Expression of the CD34 gene in vascular endothelial cells. Blood 75:2417-2426.
18. Gentile V, Saydak M, Chiocca EA, Akande O, Birckbichler PJ, Lee KN, Stein JP, and Davies PJ (1991). Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminases. J Biol Chem 266:478-483.
19. Gentile V, Thomazy V, Piacentini M, Fesus L, and Davies PJ (1992). Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: Effects on cellular morphology and adhesion. J Cell Biol 119:463-474.
20. Greenberg CS, Birckbichler PJ, and Rice RH (1991). Transglutaminases: Multifunctional cross-linking enzymes that stabilize tissues. FASEB J 5:3071-3077.
21. Hand D, Elliott BM, and Griffin M (1988). Expression of the cytosolic and particulate forms of transglutaminase during chemically induced rat liver carcinogenesis. Biochim Biophys Acta 970:137-145.
22. Ichinose A, Bottenus RE, and Davie EW (1990). Structure of transglutaminases. J Biol Chem 265:13411-13414.
23. Ingber DE and Folkman J (1989). How does extracellular matrix control capillary morphogenesis? Cell 58:803-805.
24. Jaffe EA, Nachman RL, Becker CG, and Minick CR (1973). Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria. J Clin Invest 52:2745-2756.
25. Johnson TS, Knight CR, el-Alaoui S, Mian S, Rees RC, Gentile V, Davies PJ, and Griffin M (1994). Transfection of tissue transglutaminase into a highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth. Oncogene 9:2935-2942.
26. Knight CR, Rees RC, Elliott BM, and Griffin M (1990). The existence of an inactive form of transglutaminase within metastasising tumours. Biochim Biophys Acta 1053:13-20.
27. Knight CR, Rees RC, and Griffin M (1991). Apoptosis: A potential role for cytosolic transglutaminase and its importance in tumour progression. Biochim Biophys Acta 1096:312-318.
28. Kojima S, Nara K, and Rifkin DB (1993). Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol 121:439-448.
29. Kuchler K and Thorner J (1990). Membrane translocation of proteins without hydrophobic signal peptides. Curr Opin Cell Biol 2:617-624.
30. Kuzu I, Bicknell R, Harris AL, Jones M, Gatter KC, and Mason DY (1992). Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol 45:143-148.
31. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
32. Li ML, Aggeler J, Farson DA, Hatier C, Hassell J, and Bissell MJ (1987). Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc Natl Acad Sci USA 84:136-140.
33. Lindstedt R, Apodaca G, Barondes SH, Mostov KE, and Leffler H (1993). Apical secretion of a cytosolic protein by Madin-Darby canine kidney cells. Evidence for polarized release of an endogenous lectin by a nonclassical secretory pathway. J Biol Chem 268:11750-11757.
34. Lorand L (1986). Activation of blood coagulation factor XIII. Ann NY Acad Sci 485:144-148.
35. Lorand L and Conrad SM (1984). Transglutaminases. Mol Cell Biochem 58:9-35.
36. Martinez J, Chalupowicz DG, Roush RK, Sheth A, and Barsigian C (1994). Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry 33:2538-2545.
37. Menter DG, Patton JT, Updyke TV, Kerbel RS, Maamer M, Mclntire LV, and Nicolson GL (1991). Transglutaminase stabilizes melanoma adhesion under laminar flow. Cell Biophys 18:123-143.
38. Mignatti P, Morimoto T, and Rifkin DB (1992). Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 151:81-93.
39. Mosher DF, Schad PE, and Vann JM (1980). Cross-linking of collagen and fibronectin by factor XIIIa: Localization of participating glutaminyl residues to a tryptic fragment of fibronectin. J Biol Chem 255:1181-1188.
40. Nara K, Ito S, Ito T, Suzuki Y, Ghoneim MA, Tachibana S, and Hirose S (1994). Elastase inhibitor elafin is a new type of proteinase inhibitor which has a transglutaminase-mediated anchoring sequence termed βcementoin.β J Biochem (Tokyo) 115:441-448.
41. Newman PJ, Berndt MC, Gorski J, White GC II, Lyman S, Paddock C, and Muller WA (1990). PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247:1219-1222.
42. Piacentini M, Fesus L, Farrace MG, Ghibelli L, Piredda L, and Melino G (1991). The expression of "tissue" transglutaminase in two human cancer cell lines is related with the programmed cell death (apoptosis). Eur J Cell Biol 54:246-254.
43. Prince CW, Dickie D, and Krumdieck CL (1991). Osteopontin, a substrate for transglutaminase and factor XIII activity. Biochem Biophys Res Commun 177:1205-1210.
44. Rice RH and Green H (1978). Relation of protein synthesis and transglutaminase activity to formation of the cross-linked envelope during terminal differentiation of the cultured human epidermal keratinocyte. J Cell Biol 76:705-711.
45. Rubartelli A, Cozzolino F, Talio M, and Sitia R (1990). A novel secretory pathway for interleukin-1 beta, a protein lacking a signal sequence. EMBO J 9:1503-1510.
46. Sane DC, Moser TL, Pippen AM, Parker CJ, Achyuthan KE, and Greenberg CS (1988). Vitronectin is a substrate for transglutaminases. Biochem Biophys Res Commun 157: 115-120.
47. Sporn MB and Roberts AB (1990). The transforming growth factor-βs. In: Sporn MB and Roberts AB, editors. Peptide growth factors and their receptors I, vol 95. New York: Springer-Verlag, 419-472.
48. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Cliff SM, Bissell MJ, and Werb Z (1994). Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 125:681-693.
49. Towbin H, Staehelin T, and Gordon J (1979). Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
50. Turner PM and Lorand L (1989). Complexation of fibronectin with tissue transglutaminase. Biochemistry 28:628-635.
51. Yamazaki K and Eyden BP (1995). Ultrastructural and immunohistochemical observations on intralobular fibroblasts of human breast, with observations on the CD34 antigen. J Submicrosc Cytol Pathol 27:309-323.